Gonorrhea Workup

  • Author: Nicholas John Bennett, MB, BCh, PhD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Apr 3, 2012
 

Diagnostic Procedures

In women with symptoms and signs suggestive of pelvic inflammatory disease (PID) who are difficult to diagnose clinically, laparoscopy may be indicated to rule out (and, if need be, treat) appendicitis, ovarian torsion, ectopic pregnancy, or other surgical emergencies.

Imaging studies such as ultrasonography are obviously a less invasive means of obtaining diagnostic information, but potentially emergent cases may require a more definitive examination, which permits rapid intervention if required.

Perform lumbar puncture and joint aspiration, if indicated by clinical findings.

Culdocentesis, although rarely indicated, may demonstrate free purulent exudate and provide material for Gram stain and culture.

Next

Approach Considerations

Culture is the most common diagnostic test for gonorrhea, followed by the DNA probe, and then polymerase chain reaction (PCR) and ligand chain reaction (LCR). The DNA probe is an antigen detection test that uses a probe to detect gonorrhea DNA in specimens.

Always obtain a pregnancy test for women of childbearing age who present with gonorrhea or any other sexually transmitted diseases (STD).

Culture and nonculture for N gonorrhoeae

Perform a culture or nonculture detection test for N gonorrhoeae on endocervical, urethral, pharyngeal, or rectal discharge. Because organisms are intracellular, attempt to obtain specimens in a manner that will contain mucosal cells and not merely discharge (similar to a Papanicolaou smear).

Nonculture tests are less accurate in the presence of blood or during menses. Use culture instead at these times.

Culture is performed on Thayer-Martin plates that must be stored refrigerated but warmed to room temperature before obtaining sample. The plate is then incubated in a carbon dioxide atmosphere. Poor technique drastically reduces test sensitivity.

Medicolegal cases (eg, child abuse, rape) require culture due to the possibility of false-positive results with nonculture methods. However, performing the more sensitive PCR-based tests to raise the likelihood of detecting an infection, and then following up with culture to produce admissible evidence, is appropriate.

Other STDs

Other tests that might be indicated are those for concurrent STDs. Patients in whom gonococcal disease is suspected should be evaluated for syphilis infection as well as infection with Chlamydia trachomatis (high rate of asymptomatic carriage), human immunodeficiency virus (HIV) (with counseling), hepatitis B virus (HBV), herpes simplex virus (HSV), and any STDs that are suggested by the history and physical examination findings. Administer HBV vaccination to these individuals unless they have received the full vaccine series.

Rapid HIV test technology makes testing in the emergency department (ED) and referral more practical than enzyme-linked immunosorbent assay (ELISA). The need for additional testing depends on the situation; they are often performed as a battery of tests in suspected rape and child abuse cases.

HIV testing in cases of rape or new-onset abuse does not acutely diagnose a new infection but does establish a baseline status of the patient such that subsequent seroconversion might be linked back to the event in question.

Previous
Next

Gram Stain and Culture

Gram stain

Gram stain is a rapid and inexpensive test available in many emergency departments (EDs). The positive predictive value (PPV) is high for urethral infection, but a negative Gram stain does not rule out infection in asymptomatic men.

Collect specimens from the urethra, endocervix, pharynx, rectum, conjunctiva, urine, or blood.

A Gram stain of urethral or cervical discharge may show gram-negative intracellular diplococci (diagnostic in the male) and polymorphonuclear cells. This is very useful if the physician has easy access to a microscope, because the diagnosis may be made without waiting for culture results.

Sensitivity and specificity of the Gram stain are lower for endocervical specimens and rectal specimens. Gram stains from these sites are not recommended for routine use in the ED. In addition, Gram staining is not useful for the diagnosis of pharyngeal infection, because the oropharynx may be colonized by other Neisseria species that can lead to false-positive results.

Culture

Specific culture of a swab from the site of infection is a criterion standard for diagnosis at all potential sites of infection and can potentially guide treatment by determining antibiotic susceptibility.

N gonorrhoeae is a fastidious organism that requires moist carbon dioxide-rich atmosphere and must be grown on enriched media, usually chocolate agar containing lysed blood. Empiric treatment is often necessary because culture results are not available for 24-48 hours.

Cultures are particularly useful when the clinical diagnosis is unclear, when a failure of treatment has occurred, when contact tracing is problematic, and when legal questions arise.

Suspected disseminated gonococcal infection

When disseminated gonococcal infection (DGI) is suspected, blood and joint effusions should be sent for Gram stain and culture, although negative Gram stain results and sterile cultures do not rule out disseminated disease. Cerebrospinal fluid should be stained and cultured if signs or symptoms of meningitis are present.

Gram stains, cultures, and/or nucleic acid amplification tests (NAATs) of genital, rectal, conjunctival, and pharyngeal secretions should also be obtained when disseminated gonococcal infection is suspected, even if the patient has no localized symptoms at any of those sites.

Previous
Next

Nucleic Acid Amplification Tests

Nucleic acid amplification tests (NAATs) are designed to amplify sequences of DNA unique to a given pathogen, such as Neisseria gonorrhoeae. These tests are more sensitive and specific than nonamplification techniques.

Several US Food and Drug Administration (FDA)–approved NAATs are available for the detection of N gonorrhoeae in urethral swab specimens obtained from males; endocervical swabs; and urine specimens obtained from men and women. These tests are more rapid than culture, more specific than immunoassays, and do not require viable organisms.[8]

NAATs may be of particular use when examination and mucosal swab are difficult (in children or extremely apprehensive patients), and urine specimens are more easily obtained. However, although these tests can be used on eye secretions, their performance is less well validated. In addition, NAATs are not all recommended for rectal and pharyngeal specimens at this time.

Clinicians should be familiar with specimen collection guidelines and performance parameters of the test available at their own hospitals.

Suspected disseminated gonococcal infection

NAATs of genital, rectal, conjunctival, and pharyngeal secretions should also be obtained when disseminated gonococcal infection is suspected, even if the patient has no localized symptoms at any of those sites.

Previous
Next

PCR and LCR

Polymerase chain reaction (PCR) and ligand chain reaction (LCR) are gene amplification techniques that markedly increase the sensitivity of specimen testing. Both techniques amplify the genetic fingerprint of specimens with very few organisms present in order to more easily detect and identify the organisms. Although the sensitivity is significantly increased, these methods of diagnosis are many times more expensive than culture or DNA probe. In many settings, PCR and LCR are not readily available, because they may require a specialized laboratory facility. False positives are generally due to laboratory error (inadvertent contamination).

Previous
Next

Ultrasonography

Ultrasonography may be indicated in women to investigate suspected pelvic inflammatory disease (PID) and to visualize the appendix and ovaries as other possible causes of the symptoms. Pelvic ultrasonography or computed tomography (CT) scanning may demonstrate thick, dilated fallopian tubes or abscess formation.

PID is uncommon in pregnancy when the cervical mucous plug may provide some protection to the upper tract. Ultrasonography should be used to rule out ectopic pregnancy whenever a pregnant patient has signs and symptoms of possible PID.

Previous
 
 
Contributor Information and Disclosures
Author

Nicholas John Bennett, MB, BCh, PhD,  Assistant Professor in Pediatrics, Division of Infectious Diseases, Connecticut Children's Medical Center

Nicholas John Bennett, MB, BCh, PhD, is a member of the following medical societies: Alpha Omega Alpha and American Academy of Pediatrics

Disclosure: Nothing to disclose.

Coauthor(s)

Joseph Domachowske, MD  Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Joseph Domachowske, MD  Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References
  1. [Guideline] CDC. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. Apr 13 2007;56(14):332-6. [Medline]. [Full Text].

  2. Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. Jan 2006;33(1):36-51. [Medline].

  3. Centers for Disease Control and Prevention. 2009 Sexually transmitted diseases surveillance: gonorrhea. Available at http://www.cdc.gov/STD/stats09/gonorrhea.htm. Accessed 5/27/11.

  4. Mulye TP, Park MJ, Nelson CD, Adams SH, Irwin CE Jr, Brindis CD. Trends in adolescent and young adult health in the United States. J Adolesc Health. Jul 2009;45(1):8-24. [Medline].

  5. Goodyear-Smith F. What is the evidence for non-sexual transmission of gonorrhoea in children after the neonatal period? A systematic review. J Forensic Leg Med. Nov 2007;14(8):489-502. [Medline].

  6. Trent M, Haggerty CL, Jennings JM, Lee S, Bass DC, Ness R. Adverse adolescent reproductive health outcomes after pelvic inflammatory disease. Arch Pediatr Adolesc Med. Jan 2011;165(1):49-54. [Medline].

  7. García PJ, Holmes KK, Cárcamo CP, Garnett GP, Hughes JP, Campos PE, et al. Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet. Mar 24 2012;379(9821):1120-8. [Medline].

  8. Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn. Feb 2006;8(1):3-15. [Medline]. [Full Text].

  9. Gonococcal Isolate Surveillance Project (GISP) Annual Report 2005. Sexually Transmitted Disease Surveillance 2005 Supplement. CDC; January 2007. [Full Text].

  10. Availability of cefixime 400 mg tablets--United States, April 2008. MMWR Morb Mortal Wkly Rep. Apr 25 2008;57(16):435. [Medline].

Previous
Next
 
Rates of gonococcal infection per 100,000 by state and outlying regions (2009). Data from the Centers for Disease Control and Prevention (CDC):
Rates per 100,000 of gonorrhea, reported by age and sex (2009). Data from the Centers for Disease Control and Prevention (CDC):
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.